Solara Active Pharma Sciences reports consolidated net profit of Rs 28.46 crore in the September 2026 quarter

Sales rise 33.11% to Rs 417.34 crore

Net profit of Solara Active Pharma Sciences reported to Rs 28.46 crore in the quarter ended September 2026 as against net loss of Rs 10.10 crore during the previous quarter ended September 2025. Sales rose 33.11% to Rs 417.34 crore in the quarter ended September 2026 as against Rs 313.54 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	417.34	313.54	33
OPM %	18.41	11.08	-
PBDT	59.60	14.39	314
PBT	32.96	-10.10	LP
NP	28.46	-10.10	LP

Powered by Capital Market - Live News